Per 
You are reading an outdated version of this article. Information may or may not be obsolete.
Special Containment Procedures: All instances of SCP-FEAR-1 are to be placed in standard concrete humanoid containment cells at Site-XX. Cells should be no less than five meters apart from each other. Specimens are not to interact in any case (See Testing Log XXXXX). SCP-FEAR-1 are provided with adequate sources of nutrition daily as approved by the Ethics Committee as well as forty-five minutes of mental stimulation every second day.
Blood is to be taken routinely from all D-Class personnel of the Foundation and tested in a lab for C21H30O5 levels. If results conclude that the subject is infected by SCP-FEAR, it is designated SCP-FEAR-1 and contained as stated above.
Description: SCP-FEAR is the classification of a disease solely afflicting D-Class personnel1 caused by an anomalous concentration of a naturally occurring human chemical at fifty micrograms per deciliter of blood or higher. Short-term symptoms of SCP-FEAR include tachycardia, excess expulsion of water from the pores, hyperventilation, and fever, although those infected for several weeks tend to also experience facial swelling and insomnia. Experimentation into the contagious properties of SCP-FEAR is halted following Incident-XXXXX (see below).
Discovery: The first incident of SCP-FEAR was reported by Doctor ██████at Site-XX while reviewing chemical analysis of D-XXXXXX blood found after the breach of SCP-████. Blood had an abnormally high level of C21H30O5, later confirmed by Doctor ██████ to be impossible in naturally-occurring humans. D-XXXXXX is labeled “Patient Zero” of SCP-FEAR infections. Further blood testing on D-Class personnel of Site-XX proved that approximately 0.5% 4% 20% of the Site-XX D-Class population has become an instance of SCP-FEAR-1.
